It exhibits potent activity across 97% of rhinoviruses and other respiratory enteroviruses. Altesa BioSciences holds exclusive global rights to develop, manufacture, and commercialize vapendavir.

umcutrecht.nl Objective To assess the severity of the disease and the long-term cardiac prognosis for neonates who developed enterovirus (EV) myocarditis within the first weeks of life. Design ...

The Maine CDC is excited to announce that we are modernizing our Tuberculosis (TB) reporting system. Currently, inactive TB (also known as Latent TB Infection or LTBI) cases and suspect and confirmed ...

September 5, 2018 - Advisory (PDF) Prevention of Perinatal HIV in Maine - ...